Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.19

+0.15 (0.26%)

as of Jun 26, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

DON'T BUY

In the event of a market correction, they might benefit because of all the hedging they have done. To him, a permanent marker against them is their error in writing unhedged insurance premiums.

Wealthica Track your Stocks in your Watch List

HOLD

Historically they have taken too much risk and not hedged enough on their balance sheet. If you have a 2-year horizon, this is a good entry point.

DON'T BUY

Doesn’t own their equities but does own their bonds. Not his favourite name. Quite a valuation discount compared to other Cdn lifecos. Management track record is not as good as others so valuation difference is warranted.

BUY

Doesn’t expect they will raise dividends, as they are worried about battening down the hatches. Were very exposed to the equity and bond markets but are less vulnerable now. They are hoping for a 32% ROE. Great assets in Asia, which will be their growth profile. Mid $20’s in the next year or two would be appropriate.

HOLD

Has recovered off the bottom quite nicely. They are definitely de-risking their business. Have to get back to operating their core operations of insurance and wealth management. Will get a higher multiple with more stable earnings. Good long-term hold.

BUY

Benefiting from 3 things. 1) as bond yields go up insurance companies make more money 2) took a huge hit from their stock market exposure and as the market goes up they can unwind those losses and 3) their life insurance business continues to grow in Asia.

WAIT

Resistance at mid ’09 level, which we are almost at. He would rather pay more and have it break above.

BUY

With the stock market and bond yields going up, the stock price is going up. In terms of valuation, if you take out their Asian life insurance business, you get the North American business for free. Looks like it is recovering and you get a 2.7% yield while you wait.

SELL

Because of the derivatives they’ve created, it is highly leveraged to the stock market. If the market heads down this will have extra leverage to the downside. If you own, consider taking profits now.

COMMENT

Reporting Feb 14th. Stock has had a good bounce. Did a big acquisition in the US. Got really clobbered when they tied their success to equity markets but have now hedged. The question now is have they hedged away the rebound. It’ll take another couple of quarters to know. (Prefers Great West (GWO-T) through Power Financial (PWF-T).)

WAIT

Drop in later half of year was quite dramatic. The recovery is quite good now. Growth in Asia will add to bottom line. Things are stabilizing. There is a wait and see attitude. Get out below $17, could go up a dollar from here to $19.

HOLD

Was stopped out of this some time ago and has not got back in. Currently doing a $5 billion hedging program. Neutral on this but not interested in owning it here.

COMMENT

A warrant on the stock market. Has been moving heaven and earth to get over the annuity product risk. Have sterilized about 60% but it still leaves 40% so stock and earnings forecasts rip up and down with the stock. Probably twice as volatile as the market itself. Could give you 10%-15% more but bear in mind what you are holding.

DON'T BUY

First class insurance company in spite of their health care division in the US. Also expanding into the far east. Annoyed that there are 2 jobs in analyzing them. 1st is the basic industry and 2nd what the market’s going to do to impact the company.

BUY

Thinks this will finally be the year for the rebound of the stock. Expecting about $2 a share. Believes it’s trading under Book Value. Asian division is growing at an extremely high rate.

Showing 1,336 to 1,350 of 2,281 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)